M, Vaishnaav, et al. “Targeting Metabolic Pathways for Neurodegeneration: The Emerging Role of Anti-Diabetic and Lipid-Lowering Agents”. International Journal of Allied Medical Sciences and Clinical Research, vol. 13, no. 4, Nov. 2025, pp. 633-42, doi:10.61096/ijamscr.v13.iss4.2025.633-642.